GATA-3 protects against severe joint inflammation and bone erosion and reduces differentiation of Th17 cells during experimental arthritis
Article first published online: 26 FEB 2009
Copyright © 2009 by the American College of Rheumatology
Arthritis & Rheumatism
Volume 60, Issue 3, pages 750–759, March 2009
How to Cite
van Hamburg, J. P., Mus, A.-M., de Bruijn, M. J. W., de Vogel, L., Boon, L., Cornelissen, F., Asmawidjaja, P., Hendriks, R. W. and Lubberts, E. (2009), GATA-3 protects against severe joint inflammation and bone erosion and reduces differentiation of Th17 cells during experimental arthritis. Arthritis & Rheumatism, 60: 750–759. doi: 10.1002/art.24329
- Issue published online: 26 FEB 2009
- Article first published online: 26 FEB 2009
- Manuscript Accepted: 18 NOV 2008
- Manuscript Received: 17 JUN 2008
- Dutch Cancer Society
- Dutch Arthritis Association
Rheumatoid arthritis is associated with the infiltration of T helper cells into the joints. It is unclear whether interferon-γ (IFNγ)–producing Th1 cells or the novel T helper subset, interleukin-17 (IL-17)–producing Th17 cells, are the pathogenic mediators of joint inflammation in chronic nonautoimmune arthritis. Therefore, this study was aimed at examining whether the Th2-specific transcription factor GATA-3 can regulate arthritis, in an experimental murine model, by modulating Th1 and/or Th17 cell polarization.
Arthritis was induced with methylated bovine serum albumin (mBSA) in both wild-type and CD2 T cell–specific GATA-3 (CD2–GATA-3)–transgenic mice. At days 1 and 7 after the induction of arthritis, knee joints were scored macroscopically for arthritis severity and for histologic changes. Single-cell suspensions were generated from the spleens, lymph nodes, and inflamed knee joints. Cytokine expression by CD4+ T cells was determined using flow cytometry, and IL-17 expression in the inflamed knee joints was determined by enzyme-linked immunosorbent assay. Analyses of gene expression were performed for Th17-associated factors.
Wild-type mice developed severe joint inflammation, including massive inflammatory cell infiltration and bone erosion that increased significantly over time, reaching maximal arthritis scores at day 7. In contrast, only mild joint inflammation was observed in CD2–GATA-3–transgenic mice. This mild effect was further accompanied by systemic and local reductions in the numbers of IL-17+IFNγ− and IL-17+IFNγ+, but not IL-17−IFNγ+, CD4+ T cells, and by induction of Th2 cytokine expression. Moreover, GATA-3 overexpression resulted in reduced gene expression of the Th17-associated transcription factor retinoic acid–related orphan receptor γt.
These results indicate that enforced GATA-3 expression protects against severe joint inflammation and bone erosion in mice, accompanied by reduced differentiation of Th17 cells, but not Th1 cells, during mBSA-induced arthritis.